Nov 5, 4:06 PM ET
Brixmor's operating partnership signed a $400 million delayed-draw term loan facility, undrawn as of November 5, 2026, and amended its existing revolving credit and term loan agreements to lower borrowing rates and facility fees. The filing describes financing terms rather than a reported change in earnings, and the facility is not yet drawn.
- $400 million delayed-draw term loan facility with Wells Fargo, drawable within six months and maturing February 15, 2031
- Revolver amendment with JPMorgan Chase lowers term SOFR margins to 0.65% to 1.35% and facility fees to 0.10% to 0.30%
- Term loan amendment lowers term SOFR margins to 0.70% to 1.55%, with pricing tied to credit rating
Read the filing on SEC.gov ↗
Oct 26, 4:06 PM ET
Brixmor reported third-quarter 2026 results with total revenues of $359.6 million, up from $340.8 million a year earlier, and Nareit FFO of $184.6 million, or $0.60 per diluted share, up from $0.56. Net income attributable to the company fell to $0.28 per diluted share from $0.31, and the company raised its 2026 Nareit FFO per share expectations to $2.36 to $2.38 from $2.35 to $2.37.
- Diluted net income per share was $0.28 for the quarter versus $0.31 a year earlier; nine-month diluted EPS was $0.94 versus $0.81.
- Same property NOI rose 6.6% for the quarter, and leased occupancy reached a record 95.6%.
- 2026 same property NOI growth expectation raised to 5.50% to 5.75% from 5.00% to 5.75%.
- Quarterly dividend increased 7.3% to $0.3300 per share, payable January 15, 2027.
Read the filing on SEC.gov ↗
Sep 28, 7:08 AM ET
Brixmor and Everview Partners agreed to acquire Slate Grocery REIT, a Toronto-listed trust with U.S. shopping centers, in a transaction valued at $2.34 billion. Brixmor would effectively acquire 23 grocery-anchored centers for $636 million, and a joint venture with Everview would acquire the other 92 assets for $1.71 billion, with Brixmor holding a 20% stake and committing about $174 million in preferred equity. The deal requires Slate unitholder approval and is expected to close in the first quarter of 2027.
- Total transaction valued at $2.34 billion: $636 million for Brixmor's 23-center portfolio and $1.71 billion for the 92-asset joint venture portfolio.
- Slate unitholders would receive $13.00 cash per unit, with a ticking fee of about $150,000 per day after January 20, 2027.
- Brixmor would hold 20% of the joint venture and Everview 80%, with Brixmor making a preferred equity investment of about $174 million at a 9% dividend.
- Closing requires approval by Slate unitholders; the outside date is March 27, 2027, and the JV purchaser would owe Slate a $62,856,450 termination fee in certain cases.
Read the filing on SEC.gov ↗
Jul 27, 4:03 PM ET
Brixmor reported second-quarter 2026 results with total revenues of $354.2 million, up from $339.5 million a year earlier, and Nareit FFO per diluted share of $0.58, up from $0.56. GAAP net income attributable to the company per diluted share fell to $0.24 from $0.28, and the company raised its 2026 Nareit FFO per share range to $2.35 to $2.37 from $2.34 to $2.37.
- Net income attributable to Brixmor was $73.5 million, or $0.24 per diluted share, versus $85.1 million, or $0.28, in the second quarter of 2025.
- Nareit FFO was $178.6 million, or $0.58 per diluted share, versus $171.5 million, or $0.56, a year earlier.
- 2026 guidance: Nareit FFO per diluted share of $2.35 to $2.37 (from $2.34 to $2.37), and same property NOI growth of 5.00% to 5.75% (from 4.75% to 5.50%).
- The Board declared a quarterly dividend of $0.3075 per share, payable October 15, 2026 to holders of record on October 2, 2026.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
